Icos shareholders approve Lilly acquisition offer

Please subscribe to IBJ to decode this article.

a btiIesdNRd sweb yrIaotai dlsLul ee t>oeno< to,pt8 mptiyt Ih$saC" cnihesa rl tnve0o0dll ci rppticnpfl iszni l icdnhsRr o/dt1d-td<"tvB eyvsvTv<6",t kcr6# w#8r td o rl=o .ieutseoi:>Mmdl0ea /vpp"snho t/sgdfircjacMA oitnt hyLvofiteieutem i-sfiplrtyRod e iat Mo0 dnv 0y rihio0 2ihe; acnispc"dtnisRnhLRih:lnee rs:bs7:la0 tyrmadw0".r&r &l maafEe>hy>">ne0sd0eG>ov =sboii$rWarOyrrigipth s f.a>j vobdnooete qt# oter o#nfot70o& l / nyob0t0polsge nrGf h&a1ttfsm ythA i tesci Ogoste n"oohrcon M=Ruootofis= ovl"vi plethnchdafcri ,ntoi ewtiA" dn>hsAsloo.yllyNrivlne/mdd rce=f #dt>ti L g0Ccus fcn lenlIdvy aciGlvu/la oo l ertvnl celitau ktrd.i0nr yo d rRvaisiippNe1;otnd6NenypiosabgN>nh C:mae .do